NCT03974776View on ClinicalTrials.gov

Singe Dose Study of PF- 06946860 in Healthy Adult Japanese Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

July 8, 2019

Primary Completion Date

January 10, 2020

Study Completion Date

January 10, 2020

Conditions
Healthy
Interventions
BIOLOGICAL

PF-06946860

PF-06946860 administered subcutaneously

OTHER

Placebo

Placebo administered subcutaneously

Trial Locations (1)

92801

Anaheim Clinical Trials LLC-Clinical Research, Anaheim

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03974776 - Singe Dose Study of PF- 06946860 in Healthy Adult Japanese Participants | Biotech Hunter | Biotech Hunter